Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients.

MLA

Westerdijk, K., et al. “Real-World Data on the Management of Pazopanib-Induced Liver Toxicity in Routine Care of Renal Cell Cancer and Soft Tissue Sarcoma Patients.” Cancer Chemotherapy & Pharmacology, vol. 93, no. 4, Apr. 2024, pp. 353–64. EBSCOhost, https://doi.org/10.1007/s00280-023-04615-7.

APA

Westerdijk, K., Krens, S. D., Steeghs, N., van der Graaf, W. T. A., Tjwa, E. T. T. L., Westdorp, H., Desar, I. M. E., & van Erp, N. P. (2024). Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients. Cancer Chemotherapy & Pharmacology, 93(4), 353–364. https://doi.org/10.1007/s00280-023-04615-7

Chicago

Westerdijk, K., S. D. Krens, N. Steeghs, W. T. A. van der Graaf, E. T. T. L. Tjwa, H. Westdorp, I. M. E. Desar, and N. P. van Erp. 2024. “Real-World Data on the Management of Pazopanib-Induced Liver Toxicity in Routine Care of Renal Cell Cancer and Soft Tissue Sarcoma Patients.” Cancer Chemotherapy & Pharmacology 93 (4): 353–64. doi:10.1007/s00280-023-04615-7.